NCT00227318 TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial Status COMPLETED Phase PHASE3
NCT00227201 The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans Status COMPLETED Phase N/A
NCT00227175 Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study Status COMPLETED Phase N/A
NCT00225667 Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers Status UNKNOWN Phase PHASE3
NCT00225030 Observational Study of the Prognosis in Treated Arterial Hypertension Status COMPLETED Phase N/A
NCT00224237 Exploring Folk Health Practices in Latinos With Chronic Medical Conditions Status COMPLETED Phase N/A
NCT00221845 Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients Status COMPLETED Phase PHASE3
NCT00219960 The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension Status COMPLETED Phase PHASE3
NCT00219193 A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients Status COMPLETED Phase PHASE3
NCT00219180 Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure Status COMPLETED Phase PHASE3
NCT00219167 A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure Status COMPLETED Phase PHASE3
NCT00219154 A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine Status COMPLETED Phase PHASE3
NCT00219141 Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00219128 A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. Status COMPLETED Phase PHASE3